DENISE CURRY: Open Payments
NPI 1891786406 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$858 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $1,076 · 2025 $858
Food & beverage: $852Education: $6
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $336 |
| E.R. Squibb & Sons, L.L.C. | 2 | $256 |
| Alkermes, Inc. | 3 | $135 |
| TMS NeuroHealth Centers Inc. | 1 | $98 |
| Teva Pharmaceuticals USA, Inc. | 1 | $33 |
Products named: CAPLYTA, COBENFY, LYBALVI, TMS NeuroHealth Centers Inc., UZEDY, ARISTADA.
Industry payments across MO — which companies pay providers there.
